Company Savior Pharma Vista Srl with Fiscal Code 29126016
recorded a turnover of 2024 of
421.905,
with a net profit of
18.758
and having an average number of employees of
4.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Savior Pharma Vista Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
167.084
176.397
193.385
224.644
253.567
239.095
247.236
306.223
374.665
421.905
Total Income - EUR
167.749
176.467
194.077
224.652
253.654
239.151
247.284
308.302
388.309
433.527
Total Expenses - EUR
160.063
164.341
184.661
213.909
244.411
226.561
234.716
287.180
360.662
411.657
Gross Profit/Loss - EUR
7.686
12.126
9.416
10.743
9.242
12.590
12.568
21.122
27.647
21.870
Net Profit/Loss - EUR
6.390
9.932
7.432
8.496
6.706
10.526
10.295
18.094
24.368
18.758
Employees
3
3
3
3
4
4
4
4
4
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 13.2%, from 374.665 euro in the year 2023, to 421.905 euro in 2024.
The Net Profit decreased by -5.474 euro, from 24.368 euro in 2023, to 18.758 in the last year.
Check the financial reports for the company - Savior Pharma Vista Srl
Financial Rating - SAVIOR PHARMA VISTA SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Savior Pharma Vista Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Savior Pharma Vista Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Savior Pharma Vista Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Savior Pharma Vista Srl - CUI 29126016
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
1.015
1.217
796
388
190
464
333
213
91
18.155
Current Assets
54.658
61.141
60.966
73.255
73.551
82.396
88.986
109.104
144.243
136.045
Inventories
14.726
15.731
18.988
24.303
33.774
36.261
30.287
39.404
42.903
48.289
Receivables
22.310
11.956
33.099
44.100
33.209
37.495
38.915
47.884
60.121
44.415
Cash
17.622
33.453
8.880
4.852
6.567
8.640
19.784
21.816
41.218
43.342
Shareholders Funds
6.435
9.977
7.476
8.539
6.748
10.567
10.335
18.135
42.448
50.043
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
49.238
52.381
54.666
65.477
66.993
72.293
78.984
91.181
101.885
104.158
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
136.045 euro in 2024 which includes Inventories of
48.289 euro, Receivables of
44.415 euro and cash availability of
43.342 euro.
The company's Equity was valued at
50.043 euro, while total Liabilities amounted to
104.158 euro.
Equity increased by 7.832 euro, from 42.448 euro in 2023, to 50.043 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Savior Pharma Vista Srl